Retinal angiomatous proliferation: clinical characteristics and treatment options (Q45104245)

9 December 2017

Retinal angiomatous proliferation: clinical characteristics and treatment options (English)

1 reference

9 December 2017

Megan A Hunter

1

1 reference

PubMed ID

15481226

9 December 2017

Mark T Dunbar

series ordinal

2

1 reference

PubMed ID

15481226

9 December 2017

Phillip J Rosenfeld

series ordinal

3

1 reference

9 December 2017

1 September 2004

1 reference

Optometry - Journal of the American Optometric Association

9 December 2017

1 reference

9 December 2017

75

1 reference

9 December 2017

9

1 reference

9 December 2017

577-588

1 reference

Retinal choroidal anastomoses and occult choroidal neovascularization in age-related macular degeneration.

9 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1529-1839%2804%2970190-6

7 January 2021

Quantitative assessment of macular edema with optical coherence tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1529-1839%2804%2970190-6

7 January 2021

Retinal angiomatous proliferation in age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1529-1839%2804%2970190-6

7 January 2021

Analysis of vascularized pigment epithelial detachments using indocyanine green videoangiography.

1 reference

https://api.crossref.org/works/10.1016%2FS1529-1839%2804%2970190-6

7 January 2021

Levels of vascular endothelial growth factor are elevated in the vitreous of patients with subretinal neovascularisation

1 reference

https://api.crossref.org/works/10.1016%2FS1529-1839%2804%2970190-6

7 January 2021

Classification of retinal pigment epithelial detachments associated with drusen

1 reference

https://api.crossref.org/works/10.1016%2FS1529-1839%2804%2970190-6

7 January 2021

Imaging of chorioretinal anastomoses in vascularized retinal pigment epithelium detachments

1 reference

https://api.crossref.org/works/10.1016%2FS1529-1839%2804%2970190-6

7 January 2021

The nature of focal areas of hyperfluorescence or hot spots imaged with indocyanine green angiography

1 reference

https://api.crossref.org/works/10.1016%2FS1529-1839%2804%2970190-6

7 January 2021

Digital Indocyanine-green Videoangiography of Occult Choroidal Neovascularization

1 reference

https://api.crossref.org/works/10.1016%2FS1529-1839%2804%2970190-6

7 January 2021

Imaging of macular diseases with optical coherence tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1529-1839%2804%2970190-6

7 January 2021

OCT imaging of choroidal neovascularisation and its role in the determination of patients' eligibility for surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1529-1839%2804%2970190-6

7 January 2021

Optical coherence tomography: an introduction to the technique and its use.

1 reference

https://api.crossref.org/works/10.1016%2FS1529-1839%2804%2970190-6

7 January 2021

Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration With Verteporfin

1 reference

https://api.crossref.org/works/10.1016%2FS1529-1839%2804%2970190-6

7 January 2021

Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes-TAP report No. 3.

1 reference

https://api.crossref.org/works/10.1016%2FS1529-1839%2804%2970190-6

7 January 2021

Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynami

1 reference

https://api.crossref.org/works/10.1016%2FS1529-1839%2804%2970190-6

7 January 2021

Acute retinal pigment epithelial tear after photodynamic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1529-1839%2804%2970190-6

7 January 2021

Intravitreal triamcinolone for refractory diabetic macular edema

1 reference

https://api.crossref.org/works/10.1016%2FS1529-1839%2804%2970190-6

7 January 2021

Intravitreal triamcinolone for refractory pseudophakic macular edema.

1 reference

https://api.crossref.org/works/10.1016%2FS1529-1839%2804%2970190-6

7 January 2021

Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion

1 reference

https://api.crossref.org/works/10.1016%2FS1529-1839%2804%2970190-6

7 January 2021

Inhibition of preretinal and optic nerve head neovascularization in pigs by intravitreal triamcinolone acetonide

1 reference

https://api.crossref.org/works/10.1016%2FS1529-1839%2804%2970190-6

7 January 2021

Angiostatic steroids. Method of discovery and mechanism of action

1 reference

https://api.crossref.org/works/10.1016%2FS1529-1839%2804%2970190-6

7 January 2021

ICGA-guided laser photocoagulation of occult choroidal neovascularization in age-related macular degeneration. Indocyanine green angiography

1 reference

https://api.crossref.org/works/10.1016%2FS1529-1839%2804%2970190-6

7 January 2021

Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1529-1839%2804%2970190-6

7 January 2021

10.1016/S1529-1839(04)70190-6

Identifiers

DOI

1 reference

9 December 2017

1 reference

PubMed ID

15481226